CBER is actively funding and supporting the introduction
of Laser Interstitial Therapy (LITT) in Victoria for patients with brain tumours and medically refractory epilepsy. LITT is a minimally invasive surgical technique that uses laser energy to precisely target and destroy abnormal brain tissue while sparing surrounding healthy structures. For patients with deep-seated tumours or epilepsy foci in eloquent brain regions, LITT offers shorter hospital stays, reduced surgical risks, and faster recovery compared to traditional open surgery. Despite its demonstrated clinical advantages and growing use internationally, LITT is not currently funded by the Australian government. CBER is working to close this gap—helping to establish access to this innovative therapy for Victorian patients through philanthropic support, advocacy, and infrastructure development.

Our team is currently currently researching a novel surgical therapy for treating and slowing down the spread of Glioblastoma. Our goal is to take this concept from a pre-clinical model to a clinical trial over the next three years.